Discovery of synthetic penaeidin activity against antibiotic-resistant fungi

Chemical Biology and Drug Design

Volumn 68, Issue 2, 2006, Pages 120-127

  Cuthbertson, Brandon J ^a   Büllesbach, Erika E ^b   Gross, Paul S ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antibiotic resistance; Antimicrobial peptides; Cryptococcus neoformans; Multidrug resistant Candida; Native chemical ligation

Indexed keywords

ANTIFUNGAL AGENT; CYSTEINE; PENAEIDIN CLASS 3; PENAEIDIN CLASS 4; PROLINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BASIDIOMYCETES; CANDIDA; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; FUNGAL STRAIN; HUMAN; HUMAN CELL; LITOPENAEUS SETIFERUS; MONOCYTE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SHRIMP;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, MICROBIAL; FUNGI; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

BASIDIOMYCOTA; CANDIDA; CRYPTOCOCCUS (TREMELLOMYCETIDAE); CRYPTOCOCCUS (TRICHOSPORONALES); DECAPODA (CRUSTACEA); FILOBASIDIELLA NEOFORMANS; FUNGI; LITOPENAEUS SETIFERUS;

EID: 33749025005     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00417.x     Document Type: Article

References (33)

1. United States. National Institute of Allergy and Infectious Deseases, National Institutes of Health. The Problem of Antimicrobial Resistance. http://www.niaid.nih.gov/factsheets/antimicro.htm [accessed on 6 September 2006].
2. Otvos L. Jr (2002) The short proline-rich antibacterial peptide family. Cell Mol Life Sci;59:1138-1150.
3. Zasloff M. (2002) Antimicrobial peptides in health and disease. N Engl J Med;347:1199-1200.
4. Zasloff M. (2002) Antimicrobial peptides of multicellular organisms. Nature;415:389-395.
5. Gueguen Y., Garnier J., Robert L., Lefranc M.P., Mougenot I., de Lorgeril J., Janech M. et al. (2006) PenBase, the shrimp antimicrobial peptide penaeidin database: sequence-based classification and recommended nomenclature. Dev Comp Immunol;30:283-288.
6. Cuthbertson B.J., Shepard E.F., Chapman R.W., Gross P.S. (2002) Diversity of the penaeidin antimicrobial peptides in two shrimp species. Immunogenetics;54:442-445.
7. Cuthbertson B.J., Bullesbach E.E., Fievet J., Bachere E., Gross P.S. (2004) A new class (penaeidin class 4) of antimicrobial peptides from the Atlantic white shrimp (Litopenaeus setiferus) exhibits target specificity and an independent proline-rich-domain function. Biochem J;381:79-86.
8. Cuthbertson B.J., Yang Y., Bachere E., Bullesbach E.E., Gross P.S., Aumelas A. (2005) Solution structure of synthetic penaeidin-4 with structural and functional comparisons with penaeidin-3. J Biol Chem;280:16009-16018.
9. Hackeng T.M., Griffin J.H., Dawson P.E. (1999) Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology. Proc Natl Acad Sci U S A;96:10068-10073.
10. Matsueda G.R., Stewart J.M. (1981) A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides. Peptides;2:45-50.
11. Hackeng T.M., Mounier C.M., Bon C., Dawson P.E., Griffin J.H., Kent S.B. (1997) Total chemical synthesis of enzymatically active human type II secretory phospholipase A2. Proc Natl Acad Sci U S A;94:7845-7850.
12. Tesser G.I., Balvert-Geers I.C. (1975) The methylsulfonylethyloxy- carbonyl group, a new and versatile amino protective function. Int J Pept Protein Res;7:295-305.
13. Dawson P.E., Muir T.W., Clark-Lewis I., Kent S.B. (1994) Synthesis of proteins by native chemical ligation. Science;266:776-779.
14. Tam J.P., Lu Y.A., Liu C.F., Shao J. (1995) Peptide synthesis using unprotected peptides through orthogonal coupling methods. Proc Natl Acad Sci U S A;92:12485-12489.
15. Tam J., Wu C.R., Liu W., Zhang J.W. (1991) Disulfide bond formation in peptides by dimethyl sulfoxide: scope and applications. J Am Chem Soc;113:6657-6662.
16. Wu J., Watson J.T. (1997) A novel methodology for assignment of disulfide bond pairings in proteins. Protein Sci;6:391-398.
17. Casteels P., Ampe C., Jacobs F., Tempst P. (1993) Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera). J Biol Chem;268:7044-7054.
18. Destoumieux D., Bulet P., Strub J.M., Van Dorsselaer A., Bachere V. (1999) Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp. Eur J Biochem;266:335-346.
19. Baily G.G., Moore C.B., Essayag S.M., de Wit S., Burnie J.P., Denning D.W. (1997) Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin Infect Dis;25:161-163.
20. Bicanic T., Harrison T.S. (2004) Cryptococcal meningitis. Br Med Bull;72:99-118.
21. D'Antonio D., Violante B., Mazzoni A., Bonfini T., Capuani M.A., D'Aloia F., Iacone A., Schioppa F., Romano F. (1998) A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies. J Clin Microbiol;36:792-795.
22. Del Poeta M., Bixel A.S., Barchiesi F., Tidwell R.R., Boykin D., Scalise G., Perfect J.R. (1999) In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp. J Antimicrob Chemother;44:223-228.
23. Fox R., Neal K.R., Leen C.L., Ellis M.E., Mandal B.K. (1991) Fluconazole resistant Candida in AIDS. J Infect;22:201-204.
24. Kappe R., Levitz S., Harrison T.S., Ruhnke M., Ampel N.M., Just-Nubling G. (1998) Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection. Med Mycol;36(Suppl. 1):207-215.
25. Merz W.G. (1984) Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol;20:1194-1195.
26. Othman N., Abdullah N.A., Wahab Z.A. (2004) Cryptococcal meningitis in an immunocompetent child: a case report and literature review. Southeast Asian J Trop Med Public Health;35:930-934.
27. Pappagianis D., Collins M.S., Hector R., Remington J. (1979) Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother;16:123-126.
28. Ruhnke M. (2006) Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets;7:495-504.
29. Yang Y., Poncet J., Garnier J., Zatylny C., Bachere E., Aumelas A. (2003) Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide. J Biol Chem;278:36859-36867.
30. Franz R., Kelly S.L., Lamb D.C., Kelly D.E., Ruhnke M., Morschhauser J. (1998) Multiple molecular mechanisms contribute to a step-wise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother;42:3065-3072.
31. Hospenthal D.R., Murray C.K., Rinaldi M.G. (2004) The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis;48:153-160.
32. Yamazumi T., Pfaller M.A., Messer S.A., Houston A.K., Boyken L., Hollis R.J., Furuta I., Jones R.N. (2003) Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol;41:267-272.
33. Blinkhorn R.J., Adelstein D., Spagnuolo P.J. (1989) Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol;27:236-240.